Deutsche Bank’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
129,750
+9,826
+8% +$89.1K ﹤0.01% 2154
2025
Q4
$806K Buy
119,924
+4,904
+4% +$37K ﹤0.01% 2306
2025
Q3
$997K Buy
115,020
+14,082
+14% +$110K ﹤0.01% 2170
2025
Q2
$636K Sell
100,938
-15,779
-14% -$104K ﹤0.01% 2329
2025
Q1
$748K Sell
116,717
-6,864
-6% -$56.7K ﹤0.01% 2296
2024
Q4
$994K Buy
123,581
+39,787
+47% +$384K ﹤0.01% 2234
2024
Q3
$1.06M Buy
83,794
+18,572
+28% +$240K ﹤0.01% 2083
2024
Q2
$826K Buy
65,222
+7,403
+13% +$74.5K ﹤0.01% 2092
2024
Q1
$276K Buy
57,819
+11,652
+25% +$54K ﹤0.01% 2651
2023
Q4
$222K Sell
46,167
-736
-2% -$4.5K ﹤0.01% 2822
2023
Q3
$340K Buy
46,903
+5,515
+13% +$44.1K ﹤0.01% 2428
2023
Q2
$308K Buy
41,388
+27,730
+203% +$218K ﹤0.01% 2641
2023
Q1
$94.7K Sell
13,658
-58,207
-81% -$536K ﹤0.01% 3350
2022
Q4
$739K Buy
71,865
+5,084
+8% +$89.7K ﹤0.01% 2238
2022
Q3
$1.22M Sell
66,781
-11,144
-14% -$483K ﹤0.01% 1859
2022
Q2
$4.01M Sell
77,925
-119,957
-61% -$6.21M ﹤0.01% 1395
2022
Q1
$14.6M Buy
197,882
+26,037
+15% +$2.32M 0.01% 939
2021
Q4
$24.6M Buy
171,845
+53,766
+46% +$9.24M 0.01% 789
2021
Q3
$24.5M Sell
118,079
-1,943
-2% -$428K 0.01% 833
2021
Q2
$25.5M Buy
120,022
+45,305
+61% +$8.3M 0.01% 822
2021
Q1
$13.5M Sell
74,717
-2,291
-3% -$457K 0.01% 1049
2020
Q4
$8.59M Buy
77,008
+36,808
+92% +$3.91M 0.01% 1104
2020
Q3
$4.36M Buy
40,200
+5,780
+17% +$704K ﹤0.01% 1320
2020
Q2
$2.87M Buy
34,420
+24,051
+232% +$920K ﹤0.01% 1588
2020
Q1
$141K Buy
10,369
+1,273
+14% +$10.8K ﹤0.01% 3108
2019
Q4
$35K Buy
9,096
+2,845
+46% +$12.3K ﹤0.01% 4101
2019
Q3
$30K Sell
6,251
-74,810
-92% -$409K ﹤0.01% 4168
2019
Q2
$474K Sell
81,061
-75,019
-48% -$590K ﹤0.01% 3303
2019
Q1
$1.72M Buy
156,080
+117,908
+309% +$3.72M ﹤0.01% 2609
2018
Q4
$1.4M Sell
38,172
-51,794
-58% -$2.01M ﹤0.01% 2643
2018
Q3
$3.38M Buy
89,966
+22,759
+34% +$641K ﹤0.01% 2496
2018
Q2
$1.8M Sell
67,207
-224,180
-77% -$7.58M ﹤0.01% 3027
2018
Q1
$12.2M Buy
291,387
+163,029
+127% +$6.55M 0.01% 1449
2017
Q4
$3.18M Buy
128,358
+7,648
+6% +$187K ﹤0.01% 2401
2017
Q3
$2.75M Buy
120,710
+76,253
+172% +$1.71M ﹤0.01% 2332
2017
Q2
$1.02M Sell
44,457
-19,258
-30% -$378K ﹤0.01% 3019
2017
Q1
$1.63M Buy
63,715
+25,779
+68% +$709K ﹤0.01% 2375
2016
Q4
$954K Buy
37,936
+6,399
+20% +$187K ﹤0.01% 2731
2016
Q3
$1.31M Sell
31,537
-39,576
-56% -$5.11M ﹤0.01% 2650
2016
Q2
$10.3M Buy
71,113
+29,128
+69% +$3.34M 0.01% 1278
2016
Q1
$4.33M Buy
41,985
+1,634
+4% +$175K ﹤0.01% 1838
2015
Q4
$6.77M Sell
40,351
-20,587
-34% -$3.17M ﹤0.01% 1581
2015
Q3
$8.62M Buy
60,938
+23,164
+61% +$5.19M 0.01% 1394
2015
Q2
$8.41M Sell
37,774
-2,066
-5% -$363K 0.01% 1441
2015
Q1
$6.59M Buy
39,840
+22,117
+125% +$3.59M ﹤0.01% 1607
2014
Q4
$2.1M Buy
17,723
+15,610
+739% +$1.63M ﹤0.01% 2637
2014
Q3
$175K Buy
2,113
+62
+3% +$5.6K ﹤0.01% 4157
2014
Q2
$188K Sell
2,051
-836
-29% -$73.5K ﹤0.01% 4162
2014
Q1
$261K Sell
2,887
-3,082
-52% -$344K ﹤0.01% 3749
2013
Q4
$610K Sell
5,969
-12,261
-67% -$866K ﹤0.01% 2961
2013
Q3
$1.15M Buy
18,230
+2,704
+17% +$152K ﹤0.01% 2875
2013
Q2
$635K Buy
+15,526
New +$673K ﹤0.01% 3013

Other funds holding NVAX

Deutsche Bank's NVAX Position: Q1 2026 in Review

Deutsche Bank increased its Novavax (NVAX) stake by 8.2% in Q1 2026, buying an estimated $89.1K and bringing the position to 129,750 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Deutsche Bank first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.5M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Deutsche Bank held 129,750 shares of Novavax worth $1.06M as of Q1 2026.
  • Deutsche Bank bought 9,826 Novavax shares in Q1 2026, an estimated $89.1K.
  • Novavax made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2154 holding.
  • Deutsche Bank first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Novavax position peaked at $25.5M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.